Group 1 - The core viewpoint of the news is that Sai Fen Technology experienced a slight decline in stock price and had notable financing activities on January 19, with a net financing outflow of 248.09 million yuan [1] - On January 19, Sai Fen Technology's financing buy amounted to 870.19 million yuan, while the financing repayment was 1,118.28 million yuan, resulting in a total financing balance of 5,832.21 million yuan [1] - The company's financing balance of 5,831.82 million yuan accounts for 1.02% of its circulating market value [1] Group 2 - Sai Fen Technology, established on March 16, 2009, is located in the Suzhou Industrial Park and specializes in the research and production of liquid chromatography materials for drug analysis and purification [2] - The company's main business revenue composition includes: industrial purification segment 33.10%, industrial purification fillers 32.65%, analytical chromatography segment 16.73%, analytical chromatography columns 13.31%, and other segments contributing smaller percentages [2] - As of September 30, 2025, Sai Fen Technology achieved an operating income of 302 million yuan, representing a year-on-year growth of 38.39%, and a net profit attributable to shareholders of 93.21 million yuan, with a year-on-year increase of 71.07% [2] Group 3 - Since its A-share listing, Sai Fen Technology has distributed a total of 27.90 million yuan in dividends [3] - As of September 30, 2025, the number of shareholders in Sai Fen Technology was 7,159, a decrease of 31.51% from the previous period, while the average circulating shares per person increased by 57.01% [2][3] - The Southern Science and Technology Innovation Board 3-Year Open Mixed Fund (506000) has exited the list of the top ten circulating shareholders of Sai Fen Technology [3]
赛分科技1月19日获融资买入870.19万元，融资余额5831.82万元